Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

HYMB vs IBB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, HYMB returned −1.0% to IBB's +37.5%, and HYMB charges 0.35% to IBB's 0.44%.

askIQ about this page

askIQ about HYMB and IBB

Net assets on Oct 27, 2026: $3.8bn for State Street SPDR Nuveen ICE High Yield Municipal Bond ETF and $11.0bn for iShares Biotechnology ETF.

At a glance
−1.0%
HYMB total return, 1 year
+37.5%
IBB total return, 1 year
0.35%
HYMB expense ratio
0.44%
IBB expense ratio

Pair scorecard

HYMB costs 0.09 points a year less; their one-year returns differ by 38.5 points; IBB is 2.9 times larger.

HYMB vs IBB: Differences, Returns & Fees
MeasureHYMBIBB
Return
Total return, 1 year−1.0%+37.5%
Drawdown
Below its high4.7%, high on Jul 2, 2026
Benchmark
What it tracksICE US Select High Yield Crossover Municipal IndexBiotech
Cost and size
Expense ratio0.35%0.44%
Net assets, as of Oct 27, 2026$3.8bn$11.0bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
In the S&P 500, by weight40%
Top ten holdings, share of the fund50%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, HYMB and IBB hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first HYMB IBB
Only in one fund ↓
Only in HYMB
PRCGEN 5.000 07/01/58 1.94%
PRCGEN 4.784 07/01/58 1.25%
BUCGEN 5.000 06/01/55 1.08%
PRC 4.000 07/01/46 0.64%
PRCGEN 4.329 07/01/40 0.61%
NYCDEV 5.000 11/15/44 0.49%
PRC 4.000 07/01/41 0.47%
CHIEDU 6.000 12/01/41 0.46%
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Check overlap with more funds →

Side by side

HYMB State Street SPDR Nuveen ICE High Yield Municipal Bond ETF IBB iShares Biotechnology ETF
Where it sits Bond ETF Thematic ETF
What it is Tracks an index of Nuveen ICE High Yield Municipal Bond Biotech
Total return, 1 year −1.0% +37.5%
Its benchmark over the same days −1.4% (AGG) not measured
Gap to its benchmark +0.4 pts vs AGG not measured
Expense ratio 0.35% 0.44%
Holdings 2105 245
Net assets, as of Oct 27, 2026 $3.8bn $11.0bn

HYMB and IBB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

HYMB and IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
HYMB

HYMB tracks an index of Nuveen ICE High Yield Municipal Bond. Over the year to Oct 28, 2026 it returned −1.0% with distributions reinvested, against −1.4% for its benchmark, the Bloomberg U.S. Aggregate Bond Index. The prospectus expense ratio is 0.35% a year. It sat 4.7% below its high of Jul 2, 2026 on Oct 28, 2026.

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

Questions people ask

Are HYMB and IBB in the same category?
HYMB is a bond ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, HYMB or IBB?
In the year to Oct 28, 2026, with distributions reinvested, HYMB returned −1.0% and IBB +37.5%.
Which is cheaper, HYMB or IBB?
HYMB is cheaper, by 0.09 percentage points a year. That is about $9 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, HYMB against IBB, data as of Oct 28, 2026. https://etfiq.com/compare/any/hymb-vs-ibb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.